A new hepatitis C treatment regimen in development appears to have extremely high cure rates, despite only requiring a person to take pills for six weeks.
Nothing else in the history of biomedical sciences has evolved faster than the treatment of hepatitis C virus (HCV) infection. Only recently did the first direct antiviral agents (boceprevir [Victrelis] and telaprevir [Incivek]) receive FDA (U.S....
A 12-week course of three direct-acting antivirals cured at least 99% of previously untreated people with genotype-1b hepatitis C infection, according to a study presented by Rajender Reddy, M.D., at CROI 2014 in Boston.
The phase-3 study, known as ...
Heterosexual HIV-infected men and women have a high prevalence of markers associated with anal cancer, such as infection with high-risk human papillomavirus (hr-HPV) and cytological abnormalities, according to study results presented at IDWeek 2013. ...
Early Treatment and Weight Management May Prevent Common Comorbidities in Young People Living With HIV
Newly diagnosed people often have two or more additional health problems, such as depression, high cholesterol or high blood pressure. But research shows all of these issues can be tackled alongside HIV.
HIV-positive people rarely receive proper screening for colorectal cancer in the U.S., making it hard for researchers to gauge just how common it is.
Research on Two Supplements Addresses HIV-Driven Inflammation in the Gut -- A Blog Entry by Jeannie Wraight
"Gastrointestinal (GI) health is proving to be a vital, though often ignored, component of HIV infection."
Lipids Respond Well to Switch From Boosted PI to Rilpivirine/Tenofovir/Emtricitabine (Complera), Study Finds
Many people who had high lipid levels while taking common HIV treatment regimens that included a protease inhibitor, such as Prezista or Reyataz, saw remarkable improvements after the switch.
How much HIV drugs contribute to organ health problems in long-term HIV med users, and ways to prevent these problems, is a hot topic in medical communities.
Vicks VapoRub may be a cheap, effective and safe topical treatment for foot fungus (also known as onychomycosis) among people living with HIV, according to results from a pilot study presented at ID Week 2012.
Onychomycosis is common in both the gen...